Factors that contribute to the association between MS and depressive disorders include the psychosocial impact of disability due to MS [107], the direct effects of lesions on brain structures involved in mood regulation and maintenance [11,108], and the potential mood fluctuations associated with some DMTs like interferon beta used in MS treatment [109,110]. Here, IFNB1 is linked to myeloid sarcoma.